These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Circulating catecholamines and metabolic effects of captopril in NIDDM patients. De Mattia G; Ferri C; Laurenti O; Cassone-Faldetta M; Piccoli A; Santucci A Diabetes Care; 1996 Mar; 19(3):226-30. PubMed ID: 8742566 [TBL] [Abstract][Full Text] [Related]
3. Circulating endothelin-1 levels in lean non-insulin-dependent diabetic patients. Influence of ACE inhibition. Ferri C; Laurenti O; Bellini C; Faldetta MR; Properzi G; Santucci A; De Mattia G Am J Hypertens; 1995 Jan; 8(1):40-7. PubMed ID: 7734095 [TBL] [Abstract][Full Text] [Related]
4. Metabolic pathways of glucose in skeletal muscle of lean NIDDM patients. Kelley DE; Mokan M; Mandarino LJ Diabetes Care; 1993 Aug; 16(8):1158-66. PubMed ID: 8375246 [TBL] [Abstract][Full Text] [Related]
5. Oral vanadyl sulfate improves insulin sensitivity in NIDDM but not in obese nondiabetic subjects. Halberstam M; Cohen N; Shlimovich P; Rossetti L; Shamoon H Diabetes; 1996 May; 45(5):659-66. PubMed ID: 8621019 [TBL] [Abstract][Full Text] [Related]
6. Low-dose iloprost infusion improves insulin action in aged healthy subjects and NIDDM patients. Paolisso G; Di Maro G; D'Amore A; Passariello N; Gambardella A; Varricchio M; D'Onofrio F Diabetes Care; 1995 Feb; 18(2):200-5. PubMed ID: 7537193 [TBL] [Abstract][Full Text] [Related]
7. Insulin stimulates endothelin-1 secretion from human endothelial cells and modulates its circulating levels in vivo. Ferri C; Pittoni V; Piccoli A; Laurenti O; Cassone MR; Bellini C; Properzi G; Valesini G; De Mattia G; Santucci A J Clin Endocrinol Metab; 1995 Mar; 80(3):829-35. PubMed ID: 7883838 [TBL] [Abstract][Full Text] [Related]
8. Similar insulin sensitivity in NIDDM patients with normo- and microalbuminuria. Nielsen S; Schmitz O; Orskov H; Mogensen CE Diabetes Care; 1995 Jun; 18(6):834-42. PubMed ID: 7555510 [TBL] [Abstract][Full Text] [Related]
9. Acute hyperinsulinemia decreases the hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in NIDDM. Cummings MH; Watts GF; Umpleby AM; Hennessy TR; Kelly JM; Jackson NC; Sönksen PH Diabetes; 1995 Sep; 44(9):1059-65. PubMed ID: 7657029 [TBL] [Abstract][Full Text] [Related]
10. Different sensitivity of glucose and amino acid metabolism to insulin in NIDDM. Luzi L; Petrides AS; De Fronzo RA Diabetes; 1993 Dec; 42(12):1868-77. PubMed ID: 8243833 [TBL] [Abstract][Full Text] [Related]
11. Influence of reduced glutathione infusion on glucose metabolism in patients with non-insulin-dependent diabetes mellitus. De Mattia G; Bravi MC; Laurenti O; Cassone-Faldetta M; Armiento A; Ferri C; Balsano F Metabolism; 1998 Aug; 47(8):993-7. PubMed ID: 9711998 [TBL] [Abstract][Full Text] [Related]
12. Effect of obesity on insulin resistance in normal subjects and patients with NIDDM. Ludvik B; Nolan JJ; Baloga J; Sacks D; Olefsky J Diabetes; 1995 Sep; 44(9):1121-5. PubMed ID: 7657038 [TBL] [Abstract][Full Text] [Related]
13. NIDDM in the elderly. Meneilly GS; Elliott T; Tessier D; Hards L; Tildesley H Diabetes Care; 1996 Dec; 19(12):1320-5. PubMed ID: 8941457 [TBL] [Abstract][Full Text] [Related]
14. Elevation of serum insulin concentration during euglycemic hyperinsulinemic clamp studies leads to similar activation of insulin receptor kinase in skeletal muscle of subjects with and without NIDDM. Klein HH; Vestergaard H; Kotzke G; Pedersen O Diabetes; 1995 Nov; 44(11):1310-7. PubMed ID: 7589829 [TBL] [Abstract][Full Text] [Related]
15. Alterations in angiotensin II release and vascular reactivity in hypertensive men: a pilot study. Gasic S; Ratheiser K; Wagner O; Nowotny P; Vierhapper H; Waldhäusl W Am J Hypertens; 1999 Nov; 12(11 Pt 1):1055-62. PubMed ID: 10604480 [TBL] [Abstract][Full Text] [Related]
16. Demonstration of glycated insulin in human diabetic plasma and decreased biological activity assessed by euglycemic-hyperinsulinemic clamp technique in humans. Hunter SJ; Boyd AC; O'Harte FP; McKillop AM; Wiggam MI; Mooney MH; McCluskey JT; Lindsay JR; Ennis CN; Gamble R; Sheridan B; Barnett CR; McNulty H; Bell PM; Flatt PR Diabetes; 2003 Feb; 52(2):492-8. PubMed ID: 12540626 [TBL] [Abstract][Full Text] [Related]
17. Obesity, type 2 diabetes, and impaired insulin-stimulated blood flow: role of skeletal muscle NO synthase and endothelin-1. Reynolds LJ; Credeur DP; Manrique C; Padilla J; Fadel PJ; Thyfault JP J Appl Physiol (1985); 2017 Jan; 122(1):38-47. PubMed ID: 27789766 [TBL] [Abstract][Full Text] [Related]